HUNTER MOREO: Open Payments
NPI 1043062334 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 41 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,767 · 2025 $1,216
Food & beverage: $1,216
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 3 | $203 |
| Teleflex LLC | 8 | $195 |
| Sumitomo Pharma America, Inc. | 8 | $195 |
| ABBVIE INC. | 9 | $193 |
| Janssen Scientific Affairs, LLC | 2 | $122 |
| Boston Scientific Corporation | 3 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $66 |
| UROGEN PHARMA, INC. | 3 | $57 |
| PFIZER INC. | 2 | $47 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $27 |
Products named: PROVENGE, GEMTESA, ERLEADA, BARRIGEL, LUPRON DEPOT, Axonics, BOTOX, UROLIFT.
Industry payments across CA — which companies pay providers there.
